Guerbet saw the highest growth of 1.99% in patent filings in May and 1.49% in grants in June in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.24% and grants by 0.74%. GlobalData’s DataBook provides a comprehensive analysis of Guerbet‘s patent filings and grants. Buy the databook here.
Guerbet has been focused on protecting inventions in European Patent Office(EPO) with six publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 75% filings and 25% grants. The European Patent Office(EPO), France(FR), Canada(CA), and Spain(ES) patent Office are among the top ten patent offices where Guerbet is filings its patents. Among the top granted patent authorities, Guerbet has 25% of its grants in European Patent Office(EPO), 12% in France(FR) and 12% in Canada(CA).
Bayer and GE HealthCare Technologies could be the strongest competitors for Guerbet
Patents related to electronic medical record (emr) systems and healthtech lead Guerbet's portfolio
Guerbet has the highest number of patents in electronic medical record (emr) systems followed by, healthtech and connected care. For electronic medical record (emr) systems, nearly 25% of patents were filed and 25% of patents were granted in Q2 2024.
Petrochemicals related patents lead Guerbet portfolio followed by diagnostic imaging, and healthcare it
Guerbet has highest number of patents in petrochemicals followed by diagnostic imaging, healthcare it, medical imaging information systems, and image management.
For comprehensive analysis of Guerbet's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.